Joe Rogan Experience #2553 - Andrew Hubermsan · Aired Sep 14, 2026
Claim summary · not a verbatim quotation
Brain tumors do not look different than brain tissue to the naked eye but feel different to the touch of a surgeon's instruments.
The finding
What the evidence shows
This is accurate for the tumors that make surgery hardest and wrong as a blanket statement. Diffuse gliomas blend into healthy brain at the edges under normal operating light, which is exactly why surgeons give patients 5-ALA dye that makes tumor cells glow red under blue light. Other common brain tumors do look different: metastases sit inside a glial pseudo-capsule that gives surgeons a visible plane to cut along, and meningiomas are typically well separated from brain tissue. The part about tumors feeling different to the instruments is real, since tumor firmness often differs from normal tissue.
Read the supporting source · pmc.ncbi.nlm.nih.gov ↗Quick answer & review status
Quick answer
Is it true that Brain tumors do not look different than brain tissue to the naked eye but feel different to the touch of a surgeon's instruments?
Partly. The claim stretches what the evidence shows. This is accurate for the tumors that make surgery hardest and wrong as a blanket statement. Diffuse gliomas blend into healthy brain at the edges under normal operating light, which is exactly why surgeons give patients 5-ALA dye that makes tumor cells glow red under blue light. Andrew Hubermsan said it (matched by voice) on Joe Rogan Experience #2553 - Andrew Hubermsan, aired Sep 14, 2026, at 1:08:25. The supporting source is pmc.ncbi.nlm.nih.gov, linked below.
The context belongs here.
No separately verified on-air correction is recorded for this check. That is not a claim that nobody corrected it.
- Attribution
- Not independently confirmed in this record
- Editorial context review
- Not recorded; generated finding
- Coverage
- One selected claim from the episode
Revisions to this check
No dated revision is recorded here. Older checks may predate this log.
Challenge this finding or add context →Keep the evidence coming.
Follow new checks in your RSS reader, or catch up with the weekly briefing on the site.
Email signup is currently unavailable.
Prefer to catch up here? Read the weekly briefing.